- Home
- CTMX vs TNYA Comparison
CTMX vs TNYA Comparison
Compare CTMX & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- TNYA
- Stock Information
- Founded
- CTMX 2008
- TNYA 2016
- Country
- CTMX United States
- TNYA United States
- Employees
- CTMX N/A
- TNYA N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- CTMX Health Care
- TNYA Health Care
- Exchange
- CTMX Nasdaq
- TNYA Nasdaq
- Market Cap
- CTMX 60.1M
- TNYA 74.5M
- IPO Year
- CTMX 2015
- TNYA 2021
- Fundamental
- Price
- CTMX $1.09
- TNYA $0.44
- Analyst Decision
- CTMX Buy
- TNYA Strong Buy
- Analyst Count
- CTMX 5
- TNYA 6
- Target Price
- CTMX $5.52
- TNYA $8.60
- AVG Volume (30 Days)
- CTMX 1.7M
- TNYA 1.8M
- Earning Date
- CTMX 05-12-2025
- TNYA 05-07-2025
- Dividend Yield
- CTMX N/A
- TNYA N/A
- EPS Growth
- CTMX N/A
- TNYA N/A
- EPS
- CTMX 0.38
- TNYA N/A
- Revenue
- CTMX $138,103,000.00
- TNYA N/A
- Revenue This Year
- CTMX N/A
- TNYA N/A
- Revenue Next Year
- CTMX N/A
- TNYA N/A
- P/E Ratio
- CTMX $2.89
- TNYA N/A
- Revenue Growth
- CTMX 36.45
- TNYA N/A
- 52 Week Low
- CTMX $0.40
- TNYA $0.39
- 52 Week High
- CTMX $2.81
- TNYA $4.78
- Technical
- Relative Strength Index (RSI)
- CTMX 77.87
- TNYA 37.91
- Support Level
- CTMX $0.63
- TNYA $0.45
- Resistance Level
- CTMX $1.04
- TNYA $0.53
- Average True Range (ATR)
- CTMX 0.10
- TNYA 0.04
- MACD
- CTMX 0.04
- TNYA 0.01
- Stochastic Oscillator
- CTMX 82.43
- TNYA 18.23
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.